May - 2018
| Previous Next | Showing Journal 3 of 7 |
 Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress SyndromeA Combes, D Hajage, G Capellier, et al for the EOLIA Trial Group, REVA, and ECMONet New Eng J Med, 2018, online first 23rd May This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
We have been waiting for EOLIA for a long time. CESAR, influenza, and advances in technology have increased the use of ECMO for ARDS but we remain unsure of its efficacy.
This is going to be heavily debated, and is a must read trial. The primary outcome, 60-d mortality, was no...